XML 17 R7.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Cash flows from operating activities:    
Net loss $ (14,376,000) $ (10,227,000)
Adjustments to reconcile net loss to net cash provided by (used) in operating activities:    
Depreciation and amortization 1,145,000 763,000
Stock-based compensation 795,000 48,000
Changes in operating assets and liabilities:    
Prepaid expenses and other assets (2,815,000) (114,000)
Accounts payable (493,000) 512,000
Accrued liabilities and other current liabilities (182,000) (707,000)
Deferred revenue (1,759,000) (35,000)
Net cash used in operating activities (17,685,000) (9,760,000)
Cash flows from investing activities:    
Purchase of property and equipment (2,067,000) (853,000)
Net cash used in investing activities (2,067,000) (853,000)
Cash flows from financing activities:    
Proceeds from initial public offering, net of issuance costs 77,264,000  
Proceeds from issuance of preferred stock, net of issuance costs   31,000,000
Proceeds from issuance of common stock 43,000  
Proceeds from the term loan 4,540,000  
Payments of the term loan   (200,000)
Net cash provided by financing activities 81,847,000 30,800,000
Net increase in cash, cash equivalents and restricted cash 62,095,000 20,187,000
Cash, cash equivalents and restricted cash—beginning of year 135,633,000 9,287,000
Cash, cash equivalents and restricted cash—end of period 197,728,000 29,474,000
Supplemental disclosures of cash flow information:    
Cash paid for interest 80,000 $ 12,000
Supplemental disclosures of noncash investing and financing activities:    
Purchase of property and equipment included in accrued liabilities 75,000  
Deferred financing costs in accrued liabilities 154,000  
Conversion of convertible preferred stock into common stock $ 162,223,000